Satellos Bioscience Inc. (TSX:MSCL)
Canada · Delayed Price · Currency is CAD 13.38
-0.47 (-3.39%)
Aug 14, 2026, 3:59 PM EST
Satellos Bioscience Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
21
Market Cap
278.72M CAD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Satellos Bioscience News
- 1 day ago - Satellos Reports Second Quarter 2026 Financial Results and Highlights Company Progress - GlobeNewsWire
- 1 day ago - Satellos Bioscience Registration statement: Q2 2026 - Filings
- 1 day ago - Satellos Bioscience Registration statement: Q2 2026 - Filings
- 1 day ago - Satellos Bioscience Earnings release: Q2 2026 - Filings
- 3 days ago - Satellos files $300M mixed securities shelf - TheFly
- 4 days ago - Satellos Bioscience Registration statement: Registration filing - Filings
- 5 weeks ago - Satellos Bioscience DMD Drug Shows Early Promise in 6-Month Study Update - MarketBeat
- 5 weeks ago - Satellos price target raised to $18 from $11 at H.C. Wainwright - TheFly